The next step is to run clinical trials of DCA in people with cancer. These may have to be funded by charities, universities and governments: pharmaceutical companies are unlikely to pay because they can’t make money on unpatented medicines. The pay-off is that if DCA does work, it will be easy to manufacture and dirt cheap.

Full Story: New Scientist.

Click through to find out more, and find out how to you can donate to the cause. Let’s pass this one around.

(via Lupa).